Cardiac embolism refers to a condition where a blood clot, or embolus, travels from another part of the body and lodges in the heart's blood vessels, disrupting normal blood flow. This phenomenon poses a significant risk, as it can lead to serious complications, including strokes or heart attacks. The embolus typically originates in the arteries or chambers of the heart itself or may travel from other parts of the body, such as the legs, where deep vein thrombosis can occur. Prevention and management of cardiac embolism often involve anticoagulant medications to reduce the risk of blood clot formation. Understanding the underlying causes and risk factors, along with timely medical intervention, plays a crucial role in addressing and mitigating the impact of cardiac embolism on cardiovascular health.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India